In particular, the combination of sulforaphane and vitamin D has been shown to diminish cell viability in prostate cancer by inducing oxidative stress, DNA damage, and autophagy, which is linked to the upregulation of several key proteins, including BAX, CASP8, CASP3, JNK, and Nrf2 145. Here, NFE2L2 is linked to prostate carcinoma.